Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest

Refractory coronary vasospasm subsequent to reperfusion, such as cardiopulmonary resuscitation or revascularization, for myocardial infarction may respond to fasudil in the superacute phase. Continuous low‐dose fasudil administration should be an option for refractory coronary vasospastic angina (VS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooshiro, Daisuke, Yamaguchi, Satoshi, Kakazu, Masanori, Arasaki, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538208/
https://www.ncbi.nlm.nih.gov/pubmed/28781824
http://dx.doi.org/10.1002/ccr3.830
_version_ 1783254320465051648
author Ooshiro, Daisuke
Yamaguchi, Satoshi
Kakazu, Masanori
Arasaki, Osamu
author_facet Ooshiro, Daisuke
Yamaguchi, Satoshi
Kakazu, Masanori
Arasaki, Osamu
author_sort Ooshiro, Daisuke
collection PubMed
description Refractory coronary vasospasm subsequent to reperfusion, such as cardiopulmonary resuscitation or revascularization, for myocardial infarction may respond to fasudil in the superacute phase. Continuous low‐dose fasudil administration should be an option for refractory coronary vasospastic angina (VSA).
format Online
Article
Text
id pubmed-5538208
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55382082017-08-04 Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest Ooshiro, Daisuke Yamaguchi, Satoshi Kakazu, Masanori Arasaki, Osamu Clin Case Rep Case Reports Refractory coronary vasospasm subsequent to reperfusion, such as cardiopulmonary resuscitation or revascularization, for myocardial infarction may respond to fasudil in the superacute phase. Continuous low‐dose fasudil administration should be an option for refractory coronary vasospastic angina (VSA). John Wiley and Sons Inc. 2017-06-08 /pmc/articles/PMC5538208/ /pubmed/28781824 http://dx.doi.org/10.1002/ccr3.830 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Ooshiro, Daisuke
Yamaguchi, Satoshi
Kakazu, Masanori
Arasaki, Osamu
Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
title Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
title_full Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
title_fullStr Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
title_full_unstemmed Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
title_short Effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
title_sort effectiveness of continuous low‐dose fasudil on refractory coronary vasospasm subsequent to cardiopulmonary arrest
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538208/
https://www.ncbi.nlm.nih.gov/pubmed/28781824
http://dx.doi.org/10.1002/ccr3.830
work_keys_str_mv AT ooshirodaisuke effectivenessofcontinuouslowdosefasudilonrefractorycoronaryvasospasmsubsequenttocardiopulmonaryarrest
AT yamaguchisatoshi effectivenessofcontinuouslowdosefasudilonrefractorycoronaryvasospasmsubsequenttocardiopulmonaryarrest
AT kakazumasanori effectivenessofcontinuouslowdosefasudilonrefractorycoronaryvasospasmsubsequenttocardiopulmonaryarrest
AT arasakiosamu effectivenessofcontinuouslowdosefasudilonrefractorycoronaryvasospasmsubsequenttocardiopulmonaryarrest

Ejemplares similares